PG
AVNS icon

PEAK6 Group’s Avanos Medical AVNS Stock Holding History

PEAK6 Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,059
Closed -$39K – 4277
2016
Q4 		$39K Buy
+1,059
New +$37.8K ﹤0.01% 4285
2016
Q2 		– Sell
-3,603
Closed -$110K – 4276
2016
Q1 		$104K Buy
+3,603
New +$96K ﹤0.01% 3570
2015
Q3 		– Sell
-9,716
Closed -$393K – 5105
2015
Q2 		$393K Buy
+9,716
New +$436K ﹤0.01% 3020

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PEAK6 Group's AVNS Position: Q1 2017 in Review

PEAK6 Group sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 1,059 shares — an estimated $39K sold.

PEAK6 Group first reported a position in AVNS in Q2 2015 and held it in 3 quarters. The position peaked at $393K in Q2 2015. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • PEAK6 Group reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • PEAK6 Group sold 1,059 Avanos Medical shares in Q1 2017, an estimated $39K.
  • PEAK6 Group first reported a position in Avanos Medical in Q2 2015 and held it in 3 quarters.
  • PEAK6 Group's Avanos Medical position peaked at $393K in Q2 2015.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on PEAK6 Group's 13F filing for Q1 2017, filed 15 May 2017.